Address: Rheumopharm Ltd, 12 Ulitsa B. Verhovintsa, Office 108, 03148, Kiev,Ukraine
Tel: + 38 498-90-15
Rheumopharm Ltd was founded in 1994 as a company, its initial activity being the wholesale and retail trade in medicines for patients with a rheumatological profile.
Over time, the company’s activities have expanded and new activities related to participation in research projects in many fields of medicine, promote and implement new methods of modern drug therapy, and marketing activities. These activities distinguish the company from the other distributor of REVMOFARM. Today the company is successfully involved in wholesale and retail with the drug firm MUCOS Pharma GmbH & Co, Germany, from which there is agreement on joint participation in the promotion and sale of drugs Wobenzym, and FLOGENZIM VOBE-MUGOS, produced by this company. Rheumopharm Ltd has been involved in this partnership for the past 11 years.
The company’s goal – improving the health of the population of Ukraine by offering new, safe treatments and disease prevention.
Additionally, Rheumopharm Ltd is engaged in the registration of new drugs and finding them on the market. Rheumopharm has registered and re-registered in the State Pharmacological Center MoH, Ukraine and has opened up the Ukrainian market to 15 new products produced by the following companies: MUCOS Pharma GmbH & Co, Germany, PRO. MED. CS Praha of the Czech Republic, JSC ‘Biotehnos’, Romania, and Dolorgiet GmbH & Co KG, Germany.
Research work Rheumopharm Ltd company works in close collaboration with leading scholars of Ukraine in the fields of medicine: rheumatology, cardiology, dermatovenereology, hepatology, nephrology, pediatrics, urology. The research results were presented at different levels of health forums and published in medical periodical publications.
Rheumopharm employs highly-qualified specialists in various fields of medicine, managers, and pharmacists is ready to cooperate in various projects
In addition to wholesale, the company has three pharmacies in Kiev.
rheumatology, cardiology, dermatovenereology, hepatology, nephrology, pediatrics, urology
Igor Bondarenko of Ukraine’s Dnipro State Medical University, Evgeny Levenko from clinical trials company, ARENSIA, and Olena Popova from IQVIA offer their perspectives on maintaining quality and ensuring participant protection…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Here, Chieko…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Anina Adelfio…
Russia’s invasion of Ukraine has been roundly condemned by the pharmaceutical industry and almost all Big Pharmas have pledged humanitarian support to Ukraine. However, not all companies have followed the…
Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces…
Vladimir Sayenko, founding partner, and Anzhela Makhinova, counsel, of the leading Ukrainian law firm Sayenko Kharenko, give an overview on the Ukrainian pharmaceutical industry in 2017 and explain the expansion…
Tetiana Korotchenko, Country Representative of Crown Agents, one of the three international organizations contracted by the Ukrainian government to temporarily handle healthcare procurement and put an end to the plague…
Dmytro Popov, the owner, founder and CEO Elfa Group, Ukraine’s leading cosmetics manufacturer, provides his insight into Elfa’s 20-year presence in the Ukrainian market, the company’s international growth strategies and…
Dr. Maxim Sokolov, chief external specialist of the Ministry of Health of Ukraine in cardiology, principal scientist of the Department of Interventional Cardiology of the National Academy of Medical Sciences…
Dr. Paul Melekhov, vice president Eastern Europe at Pharmascience, Canada’s third largest generic company, provides insights into the unique history of Pharmascience in Ukraine and the pioneering market approach that…
Julia Sidorova, country manager of Alvogen, a new international player to the Ukrainian market, provides insights into the targeted strategy that Alvogen employs throughout the world and how this is…
Victoria Filatova, president and chairperson of the Association of Perfumery and Cosmetics of Ukraine (APCU), discusses her strategic priorities, the association’s main achievements in its six years of existence, and…
See our Cookie Privacy Policy Here